FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. HOOD
8. QCOM
9. ACN
10. AZN

Go back to FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
(NASDAQ: NRXP) Delayed: 3.47 -0.02 (0.57%)
Previous Close $3.49    52 Week High $ 
Open $3.50    52 Week Low $ 
Day High $3.54    P/E N/A 
Day Low $3.42    EPS $ 
Volume 705,971